Precigen (PGEN)
(Delayed Data from NSDQ)
$1.68 USD
+0.02 (1.20%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $1.67 -0.01 (-0.60%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.09 | -7.14% |
Earnings Summary
For their last quarter, Precigen (PGEN) reported earnings of -$0.10 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 11.11%. Look out for PGEN's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year decrease of 12.5%.
Earnings History
Price & Consensus
Zacks News for PGEN
Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services